Evaluation of Dose Distribution to Organs-at-Risk in a Prospective Phase 1 Trial of Pembrolizumab and Multisite Stereotactic Body Radiation Therapy (SBRT).

Evaluation of Dose Distribution to Organs-at-Risk in a Prospective Phase 1 Trial of Pembrolizumab and Multisite Stereotactic Body Radiation Therapy (SBRT). Pract Radiat Oncol. 2022 Jan-Feb; 12(1):68-77.

View in: PubMed

subject areas

Antibodies, Monoclonal, Humanized
Humans
Lung Neoplasms
Organs at Risk
Prospective Studies
Radiosurgery
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted

authors with profiles

Steven Chmura